Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Erasmus

Showing results (261-270 of 278) with videos related to

Pageof 28
Sort By:
Innovations (Philadelphia, Pa.)|December 27, 2019
Surveillance After Treatment of Non-Small-Cell Lung Cancer: A Call for Multidisciplinary StandardizationKyle G Mitchell, David B Nelson, Erin M Corsini, et al.
Annals of Surgery|September 12, 2013
The influence of histopathologic tumor viability on long-term survival and recurrence rates following neoadjuvant therapy for esophageal adenocarcinomaAshleigh M Francis, Boris Sepesi, Arlene M Correa, et al.
Oncology|September 12, 2012
Outcome of trimodality-eligible esophagogastric cancer patients who declined surgery after preoperative chemoradiationTakashi Taketa, Arlene M Correa, Akihiro Suzuki, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 12, 2020
Stereotactic ablative radiation therapy for pulmonary metastases: Improving overall survival and identifying subgroups at high risk of local failureDario Pasalic, Yi Lu, Sonia L Betancourt-Cuellar, et al.
Head & Neck|March 5, 2020
Outcomes and toxicities following stereotactic ablative radiotherapy for pulmonary metastases in patients with primary head and neck cancerDario Pasalic, Sonia L Betancourt-Cuellar, Nicolette Taku, et al.
JAMA Network Open|January 16, 2019
Association of Long-term Outcomes and Survival With Multidisciplinary Salvage Treatment for Local and Regional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Lung CancerEric D Brooks, Bing Sun, Lei Feng, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 31, 2016
Local Control and Toxicity of a Simultaneous Integrated Boost for Dose Escalation in Locally Advanced Esophageal Cancer: Interim Results from a Prospective Phase I/II TrialJames W Welsh, Steven N Seyedin, Pamela K Allen, et al.
The Annals of Thoracic Surgery|April 20, 2023
Gastric Extent of Tumor Predicts Peritoneal Metastasis in Siewert II AdenocarcinomaKyle G Mitchell, Erin M Bayley, Naruhiko Ikoma, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Preoperative chemo-radiation-induced ulceration in patients with esophageal cancer: a confounding factor in tumor response assessment in integrated computed tomographic-positron emission tomographic imagingJeremy J Erasmus, Reginald F Munden, Mylene T Truong, et al.
Medical Oncology (Northwood, London, England)|July 8, 2017
Post-trimodality expression levels of metadherin (MTDH) as a prognostic biomarker for esophageal adenocarcinoma patientsDilsa Mizrak Kaya, Xiaochuan Dong, Graciela M Nogueras-González, et al.
Pageof 28

Showing results (261-270 of 278) with videos related to

Sort By:
Pageof 28
Innovations (Philadelphia, Pa.)|December 27, 2019
Surveillance After Treatment of Non-Small-Cell Lung Cancer: A Call for Multidisciplinary StandardizationKyle G Mitchell, David B Nelson, Erin M Corsini, et al.
Annals of Surgery|September 12, 2013
The influence of histopathologic tumor viability on long-term survival and recurrence rates following neoadjuvant therapy for esophageal adenocarcinomaAshleigh M Francis, Boris Sepesi, Arlene M Correa, et al.
Oncology|September 12, 2012
Outcome of trimodality-eligible esophagogastric cancer patients who declined surgery after preoperative chemoradiationTakashi Taketa, Arlene M Correa, Akihiro Suzuki, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 12, 2020
Stereotactic ablative radiation therapy for pulmonary metastases: Improving overall survival and identifying subgroups at high risk of local failureDario Pasalic, Yi Lu, Sonia L Betancourt-Cuellar, et al.
Head & Neck|March 5, 2020
Outcomes and toxicities following stereotactic ablative radiotherapy for pulmonary metastases in patients with primary head and neck cancerDario Pasalic, Sonia L Betancourt-Cuellar, Nicolette Taku, et al.
JAMA Network Open|January 16, 2019
Association of Long-term Outcomes and Survival With Multidisciplinary Salvage Treatment for Local and Regional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Lung CancerEric D Brooks, Bing Sun, Lei Feng, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 31, 2016
Local Control and Toxicity of a Simultaneous Integrated Boost for Dose Escalation in Locally Advanced Esophageal Cancer: Interim Results from a Prospective Phase I/II TrialJames W Welsh, Steven N Seyedin, Pamela K Allen, et al.
The Annals of Thoracic Surgery|April 20, 2023
Gastric Extent of Tumor Predicts Peritoneal Metastasis in Siewert II AdenocarcinomaKyle G Mitchell, Erin M Bayley, Naruhiko Ikoma, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Preoperative chemo-radiation-induced ulceration in patients with esophageal cancer: a confounding factor in tumor response assessment in integrated computed tomographic-positron emission tomographic imagingJeremy J Erasmus, Reginald F Munden, Mylene T Truong, et al.
Medical Oncology (Northwood, London, England)|July 8, 2017
Post-trimodality expression levels of metadherin (MTDH) as a prognostic biomarker for esophageal adenocarcinoma patientsDilsa Mizrak Kaya, Xiaochuan Dong, Graciela M Nogueras-González, et al.
Pageof 28